![Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/44afb792-47fb-48f5-b5ed-b02bbe7c607b/gr1.jpg)
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine
![The Revised International Prognostic Index (R-IPI) Score Is Predictive Of Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era - ScienceDirect The Revised International Prognostic Index (R-IPI) Score Is Predictive Of Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497119675464-fx1.jpg)
The Revised International Prognostic Index (R-IPI) Score Is Predictive Of Survival In Aggressive Transformed Lymphomas (TL) From Low Grade Non-Hodgkin Lymphomas In The Chemoimmunotherapy Era - ScienceDirect
![Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma | Scientific Reports Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep44282/MediaObjects/41598_2017_Article_BFsrep44282_Fig1_HTML.jpg)
Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma | Scientific Reports
![Overall survival according to the Follicular Lymphoma International... | Download Scientific Diagram Overall survival according to the Follicular Lymphoma International... | Download Scientific Diagram](https://www.researchgate.net/profile/Bernd-Metzner/publication/5882500/figure/fig2/AS:264602101481473@1440097465361/Overall-survival-according-to-the-Follicular-Lymphoma-International-Prognostic-Index-19.png)
Overall survival according to the Follicular Lymphoma International... | Download Scientific Diagram
![Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ec2560c7-dc8d-4a26-90d6-6bffdd934fbd/gr1_lrg.jpg)
Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine
![Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma](https://www.spandidos-publications.com/article_images/ol/20/4/ol-20-04-11906-g01.jpg)
Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma
![High combined individual and neighborhood socioeconomic status correlated with better survival of patients with lymphoma in post-rituximab era despite universal health coverage - ScienceDirect High combined individual and neighborhood socioeconomic status correlated with better survival of patients with lymphoma in post-rituximab era despite universal health coverage - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2311300616300167-gr2.jpg)
High combined individual and neighborhood socioeconomic status correlated with better survival of patients with lymphoma in post-rituximab era despite universal health coverage - ScienceDirect
![Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-64579-z/MediaObjects/41598_2020_64579_Fig3_HTML.png)
Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports
![Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes - Annals of Oncology Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/6ad85887-3d55-4813-ae60-8b3660c3516f/gr1.jpg)
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes - Annals of Oncology
![Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Blood Cancer Journal Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-020-0299-0/MediaObjects/41408_2020_299_Fig1_HTML.png)
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Blood Cancer Journal
![Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-64579-z/MediaObjects/41598_2020_64579_Fig1_HTML.png)
Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project | Haematologica
![Overall survival of 104 patients with non-Hodgkin lymphoma after ASCT... | Download Scientific Diagram Overall survival of 104 patients with non-Hodgkin lymphoma after ASCT... | Download Scientific Diagram](https://www.researchgate.net/profile/Luis-Porrata/publication/11874557/figure/fig1/AS:351152924315656@1460732789605/Overall-survival-of-104-patients-with-non-Hodgkin-lymphoma-after-ASCT-as-a-function-of.png)
Overall survival of 104 patients with non-Hodgkin lymphoma after ASCT... | Download Scientific Diagram
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial | Haematologica
![Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials - André - 2020 - Cancer Medicine - Wiley Online Library Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials - André - 2020 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b3a0a4e8-76dd-4021-a34a-bc392c6c148c/cam43298-fig-0002-m.jpg)
Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials - André - 2020 - Cancer Medicine - Wiley Online Library
![Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients | Bone Marrow Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients | Bone Marrow](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bmt.1705792/MediaObjects/41409_2007_Article_BF1705792_Fig1_HTML.gif)
Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients | Bone Marrow
![A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-61378-4/MediaObjects/41598_2020_61378_Fig1_HTML.png)